abrdn Life Sciences Investors
HQL
45 hedge funds and large institutions have $54.3M invested in abrdn Life Sciences Investors in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 10 closing their positions.
64% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.75% less ownership
Funds ownership: 17.03% → 14.29% (-2.7%)
6% less capital invested
Capital invested by funds: $57.5M → $54.3M (-$3.19M)
8% less funds holding
Funds holding: 49 → 45 (-4)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.36M |
| 2 |
LPL Financial
San Diego,
California
|
+$1.17M |
| 3 |
OC
Oppenheimer & Co
New York
|
+$458K |
| 4 |
NPC
National Planning Corporation
El Segundo,
California
|
+$433K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$302K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
-$7.09M |
| 2 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$3.38M |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$925K |
| 4 |
Morgan Stanley
New York
|
-$771K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$650K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RFS
51
Rockefeller Financial Services
New York
| – | -$18K | -825 | Closed |
|
|
FTUS
52
Flow Traders U.S.
New York
| – | -$1K | -54 | Closed |
|
53
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$24 | +1 | +100% |
|
|
GAM
54
Gemmer Asset Management
Walnut Creek,
California
| – | +$24 | +1 | +7% |
|
HQL Hedge Fund Activity: Q4 2014 in Review
45 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q4 2014, worth a combined $54.3M — down 5.5% from $57.5M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of HQL and 7 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 18 added.
The largest buyer was Credit Suisse, opening a new position worth an estimated $2.36M. The largest seller was Advisors Asset Management, exiting entirely with an estimated $7.09M sold.
- 45 institutional investors held abrdn Life Sciences Investors (HQL) as of Q4 2014, down from 49 in Q3 2014.
- Funds reported $54.3M of abrdn Life Sciences Investors stock for Q4 2014, down 5.5% quarter-over-quarter.
- 7 funds opened new abrdn Life Sciences Investors positions in Q4 2014 and 10 closed out, a net change of -3 holders.
- The largest abrdn Life Sciences Investors buyer in Q4 2014 was Credit Suisse, an estimated $2.36M added.
- The largest abrdn Life Sciences Investors seller in Q4 2014 was Advisors Asset Management, an estimated $7.09M sold.
Based on aggregated 13F filings for Q4 2014.